INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
6.61
+0.39 (6.27%)
At close: Jun 24, 2025, 4:00 PM
6.68
+0.07 (1.06%)
After-hours: Jun 24, 2025, 7:51 PM EDT

INmune Bio Market Cap

INmune Bio has a market cap or net worth of $153.42 million as of June 24, 2025. Its market cap has decreased by -13.35% in one year.

Market Cap
153.42M
Enterprise Value
134.43M
1-Year Change
-13.35%
Ranking
Category
Stock Price
$6.61

Market Cap Chart

Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $153.42M, an increase of 97.14%. That is a compound annual growth rate of 11.21%.

History

DateMarket Cap% Change
Jun 24, 2025153.42M48.17%
Dec 31, 2024103.55M-48.97%
Dec 29, 2023202.92M78.35%
Dec 30, 2022113.78M-37.49%
Dec 31, 2021182.00M-21.41%
Dec 31, 2020231.57M270.69%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 684.73B
Johnson & Johnson 360.41B
AbbVie 327.31B
Novo Nordisk 326.28B
UnitedHealth Group 273.97B
Abbott Laboratories 231.38B
Novartis AG 227.54B
AstraZeneca 217.06B
Market Cap Rankings